Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets

  • The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation)

  • The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies

  • Roche will provide high double-digit millions of tests already in May for countries accepting the CE mark and in the U.S. under Emergency Use Authorization, further ramping up capacities thereafter

  • The test is available on Roche’s cobas e analysers which are widely available around the world



Original News

CONTACT

BioRN Network e.V.

Im Neuenheimer Feld 582

D-69120 Heidelberg

Contact us >>

INFORMATION

BioRN is the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations, supporting a rich translational ecosystem and promoting, representing and connecting the regional innovation stakeholders.

  • LinkedIn Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon
go-cluster-LOGO_RGB-WEB.jpg

"Making Life Science matter...

...and Innovation happen!"

cl_label_silber.png

© Copyright - BioRN Network e.V. -  Imprint & Legal Notice - Data Privacy Policy